MSD TENDER NUMBERS cLosING oN 0410612020 at 1O.

OO am
TENDER NO
ITEM QUANTITY PACK DETIVERY
stzE
LPlMSD/CPU-
RO/10e/(r)/ 90 01 TAB IMMEDIATELY with
DHS/N
2020
SR No 00112501 TABS 15 months Residual
valpatasvir 100mg + Sofosbuvi1400mg tablet Shelf Life
Specification valpatasvir 100mg and Sofosbuvir 4o0mg tablet
LPlMSD/CPU- MSD o/L No 2o2o/spc/B/c/p/oo24o 762 01 TAB IMMEDIATELY with
DHS/Ro/11,0/(rl/2
020
SR No 01208802 TABS 15 months Residual
Mycophenolic acid tablet 360mg Shelf Life
Mycophenolic acid tablet 360mg
Each tablet to contain 360mg of Mycophenolic acid as
Mycophenolate sodium.
Note
The shelf Life of the product should be minimum 24 month
LPlMSD/CPU. MSDO/L No 2020 / sP c / B I c I P / 00242
DHs/RO/1,1L/fi)/2 i 10 01. TAB IMMEDIATELY with
SR No 00801604
020 IABS l-5 months Residual
Rifaximin tablet 55Omg Shelf Life
Specification Rifaximin tablet 550mg
LPlMSD/CPU- MSD o/L No 2o2o/spc/B/c/p/o)2n 158 01 VIAL IMMEDIATELY with
DHS/RO/1,12/F)/2
020
SR No OL4O1,4OL
VIALS 15 months Residual
Item Adalimumab lnjection 40mg Shelf Life
Specification Adalimumab lnjection 40mg
 ITEM
QUANTITY PACK DELIVERY ]

LPlMSD/CPU- MSD O/L No SIZE

2020/sPc/o/c/P/OO4O'
D HS/N ROy'1 13/(r)/
2020
SX No 01108301
01 VIAL 40 vtAls _

IMMEDIATELY & 26
i Cladribine injectionf0mg/10nn vial vrALS - 30/06/2020
Cladribine lnjection 10mg.
with 15 months
Each vial to contain 10mg (1mg/ml)
of Cladribine, Residual Shelf Life
Note
1. This tnjection should be stable
for a minimum 24 months
when stored at a temperature range of
02 C _ 0g C
2. Each vial should be labeled accordingly.

LPlMSD/CPU. MSp o/L No I zozwsectotuetoo+os

D HS/N RO/1
2020
14l(r)/ sR No i otlotaoz 1.42 PFS _

Item I Denosumab ,rJ 60rg i" 1rl

IMMEDIATELY &
1OO PFS .
Specification ] Denosumab inj".tion OOr,g; lrrl 30/06/2o2o with 15
months Residual
LPlMSD/CPU-
1sl(r)/
MSD O/L No t,
zwo/spc/o/c/p/oo-qa8 Shelf Life
D HS/N Ra/1
2020
sRNo I 01r11s01
IMMEDIATELY -
ttem i olap.rib..p*G sorng
2O,OOO CAPS &
30/06/2020 - 1-o,s2o
Specification Olaparib..p*GGOrl- CAPS with 15
months Residual
Shelf Life
 ITEM

LPlMSD/CPU- rrasoo/rruo
DHS/N RQ/116l(r)/ @ O1 VIAL IMMEDIATELy with
2020
months Residual
1.5
Cabazitaxel tnj. 60 mg /1.5;l vial
Shelf Life
Cabazitaxet tnjection oo rgTlj;lfil *ith rol*nt.
Each 1.5m1 vial to contain 60mg of
Cabazitaxel for solution for
infusion.
Note:
01. This injection should be stable for
a minimum of 24 months
when stored at a temperature below 30
C
02. Each Vial should be labeled accordi
LPlMSD/CPU- MSDo/LNo M
DHS/Ra/fi7/(E)/2
020 !L No 51r0rro1
01 VIAL IMI\4EDIATELY -
Item Bevacizumab ,lf00rg/4,,ilrd
L,500 vtALS &
30/06/2020 - 1-,1.28
Bevacizumab lnjection lOlmgl 4ml
VIALS with i.5
Each 4ml vial to contain 100mg of
Bevacizumab for months Residual
intravenous infusion.
Shelf Life
Note :

1.The product should be stable for a minimum

of 24 months
when stored within a
temperature range of 2,C_g,C.
2.Each vial should be labelled
 QUANIITY
LPlMSD/CPU- MSD O/L No
DHS/RO/118/(El/2
2o2o/sPc/o/c/i/oo43i
SR No 01,20sL02 01 VIAL IMMEDIATELY - 4OO
020
Item Trastuzumab injection 440mgvial VIALS
30/06/2020 _ 327
Trastuzumab inle
VIALS with t5
Each 20ml vialto contain 440 mgof
Trastuzumab with suitable months Residual
solvent for
Shelf Life
intravenous use
Note:
1. The product should be stored
at 2_g,C
2. Each vial should be labelled accordingly
3. The shelf life of the product should
be minimum of 24
months
LPlMSD/CPU-
2020/sPC/o/c/P/oo4:4
DHs/Ra/ns/fi]}/2
012L210L IMMEDIATELY.
o20
1,540 CAPS &
Lenvatinib Capsule 1.0 mg
Specification j i.nr.tinif 30/06/2020 - L,000
C.prrlu fO rng CAPS with 15
months Residual
MSp o,/L No t zuotspcjorcntooqu Shelf Life
SR No ,,
ol21,2LO2 600 CAPS -

It"q Lenvatinib C.prrb 04 rnC

IMMEDIATELY &
Specification r Lenvatinib 30/06/2020 - s8o
Lenvatinih Capsule
can<r,to 04 *^
nr mg
CAPS with 15
months Residual
LPlMSD/CPU- ttttsoo/tNo @ Shelf Life
DHS/ROt121./F)/2
020
sR No 2OO VIALS -
IMMEDIATELY &
Docetaxel TpGS injectiong0mg/Sml vial
"ot21,O4O1 30/06/2020 - 1.28
Specification
1succrnate micelles for injection g0mg/gml
t vryL(rryr cfv.A VIALS with 15
vial months Residual
Shelf Life
I TENOER NO
I trEM
QUANTITY
LP/MSD/CPU-
DHS/Ra/Q2/(1',/2
rvrsoo/tNo Tozo/ic/o/c/p/ooqs7
020
sR No , otioqoz 264 VIALS .
IMMEDIATELY &
Docetaxel TpGS injection20mg/2ml
vial 2OO VIALS -
I formulated in ro@
-Docetaxel mirpllec fnr ini^-+;^^ 1n*^/..
30/06/2020 with 1s
I SUccinate
Succinate micelles for injection ZOmg/2ml| ,
vial months Residual
LPlMSD/CPU-
DHS/RoJ1,24/lE)/2
rvtiD04No t2oW Shelf Life

020
sR No }LZO4TO- IMMEDIATELY. 5OO

Sunitinib Malate capsuterZSmj

CAPS & 30/06/2020
- 340 CAPS with 15
unitinib Malate capsules 12.5mg
months Residual
Each capsule to contain 12.5mg of Sunitinib
Maleate. Shelf Life

01.The shelf life of the product should

be minimum of 24
months
LPlMSD/CPU
DHS/RoJ1.2s/(El/2
MSp o/L No I zozo1sec10p1p1so3s7

o20
sR No io1ro8so1
IMMEDIATELY -
25,OOO TABS &
Abiraterone acetate tablet250mg
30/0612020 - 20,276
Specification in@
I Each tablet to contain 250mg TABS with 15
of Abiraterone acetate. months Residual
I Note :
Shelf Life
1. The Shelf Life of the product should
be minimum of 24
 LPlMSD/CPU. MSD O/L No t zozo/spctorctp/o4oo
DHS/RO/726/(E)/2
020
5R No ] orzosoor
01 VIAL 60 VIALS.
IMMEDIATELY & 48
Item Bendamustine HCI inj
vtALS 30/06/2020
Bendamustine hydrochloride injection, 100mg with 15 months
h 2Oml vtal
Each 20ml vial to contain 100mg of Bendamustine Residual Shelf Life
hydrochloride as lyophilized
powder for intravenous use.

Note;
1. This
injection should be stable for a minimum of 02
years when stored under store below 25,C
2. Each vial should be labeled accordin
LPlMSD/CPU. MSp O/L No i zozo/sp:c/olc/p/ooao8
DHS/Ra/D7/(El/2
o20
SR No j orzo:tor
600 VIALS -
IMMEDIATELY &
Cetuximab injection 100mg vial
368 VIALS
Cetuximab injection Smg/ ml, 20ml vial 30/06/2020 with 15
Each 20ml vial to contain 5 mg/ml of Cetuximab, months Residual
solution for
infusion Shelf Life
Note;
1. This in.jection should be stable for a minimum
of 24 months
when stored at a temperature range of 2,C_g,C
2. Each vial should be labeled
LPlMSD/CPU- MSD O/L No 2O2O/SPC/Orc/P/OO4i}
DHS/RO/L28/(E)/2 01 TAB 6,000 TABS -
020 IMMEDIATELY &
Pazopanib tablet 200mg
5,640 TABS .
Specification Pazopanib tablet 20Omg 30/06/2020 with 15
Each tablet to contain 200 mg Pazopanib (as hydrochloride) months Residual
Note: Shelf Life
01.The shelf life of the product should be minimum of 24
months
 QUANTITY
LPlMSD/CPU-
DHS/RoJL2e/(E)/2
vsoo/Ll,ro -IzozoApclorclp/oo+sr 13,750 7,OOO TABS .
020 J1419!l TABS IMMEDIATELY &
Regorafenib tablet
6,750 TABS -
Regorafen ib ta blet 40mg
30/06/2020 with 1s
Each film- coated tablet to contain 40mg of Regoafenib. months Residual
Note:
Shelf Life
The Sherf Life of the product shourd
be minimum of 24 months
LPlMSD/CPU.
DHS/RoJ730/(E)/2
MSp o/L No @zUspctotc/p/ooan
020
Sn No E1r1o?01 1,OOO CAPS .
Item I ceritiniOi**G rso*
IMMEDIATELY &
995 caps -
Ceritinib capsule 150mg 30/06/2020 with 15
Each capsule to contain 150 mg of
Ceritinib. months Residual
Note:
Shelf Life
01.The shelf life of the product should be
minimum of 24
months.
LPlMSD/CPU-
DHS/RO/131./(E)/2
MSD o/L No zozotspctotctptoOqaa
136 vials -
020 o7206201.
IMMEDIATELY &
f ,lqrgti, (Pegylated) inl.omglo.om I lrnt
100 vials -
Pegylated Filgrastim lnjection OmglO.Oml
f ml 30/06/2020 with L5
Each vial/pre-filled syringe to contain
6 mg of pegylated months Residual
filgrastim in 0.6 ml-1ml solution for injection. Shelf Life
Note:
l.Shelf life of the product should be minimum
of 24 months
2.Each vial/pre-filled syringe should be
labelled accordingly.
MSD O/L No 2O2O/sPc/o/c/P/oo4L3
7,000 caps -
ot21t701
IMMEDIATELY &
Enzalutamide capsule 40mg
5,360 caps -
Specification ] f nzalutamide *p-il" 40rg 07/ot/2020 with 1"5
months Residual
Shelf Life
 Tt]NDER NO
ITEM

LPlMSD/CPU-
DHS/RoJ1.33/(E)/2
MSp O/L No izontspctotctpto(/.qs
020
5R No I 01211301 4,000 caps -
pelh^.;.x IMMEDIATELY &
Item Palbociclib .-^-..r^
Capsule ,.
3,239 caps -
Specification ] palbociclib Crprrtu fZSrng 30/0512020 with 15
months Residual
LPlMSD/CPU-
DHs/RA/134/(E)/2
!!o o/!!o 2ozo/sPcrcrclp/lcr.l7 Shelf Life

020
SR No OI2Ogg0l
4,000 tabs -
IMMEDIATELY &
3,735 tabs -
Osimertinib (as mesylate) tilr_.o.t.a t.btJ AO 30/06/2020 with 1s
rr,g
Each tablet to contain g0 mg of osimertinib months Residual
as mesylate.
Note: Shelf Life
01.The shelf life of the product should be minimum
of 24
months.
tPlMSD/CPU, MSp o/L No ,,
zozolsicJoJclifuiG
DHS/RO/13s/g)/2
020
sR No ] orzoasor
4,000 caps -
IMMEDIATELY &
Item Nilotinib cap 150m!
3,246 caps -
Nilotinib hydrochloride monohydrate ..p*G f SOrng 30/612020 with 15
Each capsule to contain 150mg of Nilotinib (as months Residual
hydrochloride
monohydrate) Shelf Life
Note:
01.The shelf life of the product should be minimum
of 24
months
 I trEM
LPlMSD/CPU-
DHS/RQ/136/(Tll2
MSp o/L No lzozotsrctorctptouts
020
SR No O]2OS}O2 2,4L6 caps -
Item IMMEDIATELY &
Nilotinib cap 200mg
2,000 caps -
Nilotinib hydrochloride m@ 30/6/2020 with 15
Each capsule to contain 200mg of Nilotinib (as
hydro'chloride months Residual
Shelf Life

Of .fhe shelf life of the product should be minimum

] of 24
LPlMSD/CPU
DHS/RQ/737 /(El/7
MSp o/L No I ni/spcdrc/p/oorss
O1 VIAL IMMEDIATELy with
020
15 months Residual
Tocilizumab SOnE/ 4ml forlVinf *i* Shelf Life
Tocilizumab SO,
Each 1 ml of concentrate to contain
20 mg of tocilizumab
solution for infusion
Note:
1. This injection should be stable for
a minimum 24 months
when stored at a temperature range of 2,C _ g,C
2. Each vial should be labeled accordingly
 conditionstothc,IenderYouarercquestedtoindicatc,h.lo*,...@tha1couldbcal}brded.

Regulation Authoritv'(NMRA
ffi':fi:;k'xJ;l,r;uHlii-Meclicines - Sri Lanka) Registration cerrificate.
certificate of Anarl,sis (coA) shourd
be

In addirion' the rbllowing infbrmation

arso should be indicated in your quotation.
1. Delivery Date
2 Availability of Ex-stocks (Ex stocks are
3, Delivery Schedule / date (in case if Ex_ expected to be suppried within two (02) working days after pracing the order.
Stocts are not available)
4. Shelf Life of the item (Date of Manufacture
,nO ,.," of Expiry)
5. Related Tender Number, SR number tf," ii.,
6. Contact details of the bidder (Contac,"fr"r*n, and description of item.
rr Nos, (Land/mobile), Fax, e_mail)
Your <luotation / quotations shall be placed
in thc rclevant rcnder box; rvhich is praced
Pharmaceuticals corporalion' ptin' in the Internal Auclit Department
to rtn'lng ;;;.;; ,ir. ir;i;.t"d';;;". orthe Head ofljr:e of.the State
i^1,; Iate deliv*cJ7 rri.,i,"juia, wilr bc re,ected rvithoul
accepring)

l?i"ffiXTffi;Llli,*?lli,'JiJi':#Jiii::il1il)i;;i: ro the Adminisrrarion r)eparlmenr

on or belbre the crosing ortender
lh1;:liti.l", and

SPC reserves the right to call samples

from bidders rvho-have not submitted
samples befirre closing o.the tender in cascs o'none of rhe bidclers
had submitted
opinion of calling of samplcs ftom
thc bidtlers whlo hu.l" rut submitted ra,r-rpre,
r*il herp them to rnakc a crst erlbctive
decision.
Note
1' Prease indicate the current market whore sare and Retair
prices in your quotation (bid)
2' YourQuotation(bid) shall besubmittedinoneoriginar
andoneuupticatgseatedseparatelyandmarkedas,,oRrGrNAL,,and,,DUpLrGATE,,
respectively' Both envelopes shall
be enclosed in one envelop and deposited
3 ln case if the supplier / manufacturer
i' not
in the iendert", r."pi i.',r.," rnternar
Audit Department.
with NMRA - Sri Lanka, prease proriJe t"ir"*i.r
i) Cwp certificate '"gi'tu.ud detairs together with the bid (euotation)
ii) Certificate of pharmaceutical products
iii) Manufacturer,s information letter
iv) Certificate of Analysis of the product
(]0NDITIONS OI.' ST]PPL!'

l The Product should have minimum of 15 months shelf

life at the time of delivery at Medical supplies Division.

' fl""':J:*::.":H:3:[:JJjIliilli];,?]"rlllxpirv, Batch No, Name and address of manufacture shourd

be crearry marked on the outer covering containing

3' Offers for any other economically viable pack

sizes different from the specify pack sizes
are acceptable with the prior approval of Director Medical
Supplies Division.
4 MSD order List No' sR No' of ltem' sPC lndent
No/purchase order no Description and storage condition
I nvoices.
of item and Batch No shal be indrcated in a, suppry

5 Storage condition of the items should be clearly

indicated in the inner most and outer most carton
6 cold chain monitors should be included for each cartons Iabels.
and the cold chain shourd be maintained according
transport and delivery. to the manufacturer's instructions during storage,

7. Delivery of the items is to be made to _free of charge.

8. Withdrawalfrom use of ltem due to quality failure.

a) lncaseofbatchwithdrawalduetoqualityfailure,thesupplier/manufacturershallreimbursethevalueofentirebatchquantitysupplied.
b) lncaseofproductwithdrawalduetoqualityfailure,thesupplier/manufacturershallreimbursethevalueofentireproductquantitysuppried.
c) ln the event of either a) or b) above the supplier/manrfactur",
shall be surcharged additionar 25% of rhetotar varue
concerned as administrative cost.
9 Standard- any other pharmaceutical standard
accepted by cosmetics, devices and drugs regulatory
also acceptable. authority in sri-Lanka for registration of pharmaceutical
item

10' ln the event that item is awarded to unregistered

bidder, the NoL/PUL issued by NMRA should be submitted
released for the delivered it".. when item is delivered. rf not, payment will not be

11 ln the event of failing to supply the item within

the delivery schedule given the purchase order the
requiredbyMedical SuppliesDivisionanddecidestoaccept item wiil not be accepted by MSD. However, if the
item is stiil
ther.r",.penaltyof 0.1%of thetotar varueperdayuptoTdays(totar
delivery)' 0 3%per total value per day from Sth of 0.7%forlstTdaysof rate
to 14th (another 2.1% for 7 days from 8th to 14th day
day (another 35%for the period from 15th to of rate derivery),0.5% per totar varue per day from 15th
2l'st day of late delivery) for the lapsed period will be to 21st
ln case of an item delivered after 3 weeks, if the deducted from your payment as liquidated damage.
item is still required MSD reserves the right to accept
maximum penalty of 10% of the total value will be imposed.

13. ll,1Xt*L^i^"rT"ji1",J,?Y:j:j: l,':1":i:::l:y:.:::":lltl":-1,-!:,.lh",ender document issued bv spc are arso appricabre